Assessment of a prepulse inhibition deficit in a mutant mouse lacking mGlu5 receptors

被引:119
作者
Brody, SA
Dulawa, SC
Conquet, F
Geyer, MA
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
[3] Univ Lausanne, IBCM, GlaxoWellcome Expt Res, Lausanne, Switzerland
关键词
PPI; metabotropic glutamate; mGluR5; startle; prepulse inhibition; knockout mouse;
D O I
10.1038/sj.mp.4001404
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The glutamate hypothesis of schizophrenia derived from evidence that phencyclidine, a noncompetitive N-methyl-D-aspartate (NMDA) antagonist, produces schizophrenia-like symptoms in healthy humans. Sensorimotor gating, measured by prepulse inhibition (PPI), is a fundamental form of information processing that is deficient in schizophrenia patients and rodents treated with NMDA antagonists. Hence, PPI is widely used to study the neurobiology of schizophrenia. As the use of PPI as a model of gating deficits in schizophrenia has become more widespread, it has become increasingly important to assess such deficits accurately. Here we identify a possible role of mGluR5 in PPI by using wild type (WT) and mGluR5 knockout (KO) mice of two different background strains, 129SvPasIco and C57BL/6. In both strains, PPI was disrupted dramatically in the mGluR5 KO mice throughout a range of interstimulus intervals and sensory modalities. The present findings further support the glutamate hypothesis of schizophrenia and identify a functional role for mGluR5 in sensorimotor gating.
引用
收藏
页码:35 / 41
页数:7
相关论文
共 38 条
  • [11] Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies
    Crawley, JN
    Belknap, JK
    Collins, A
    Crabbe, JC
    Frankel, W
    Henderson, N
    Hitzemann, RJ
    Maxson, SC
    Miner, LL
    Silva, AJ
    Wehner, JM
    WynshawBoris, A
    Paylor, R
    [J]. PSYCHOPHARMACOLOGY, 1997, 132 (02) : 107 - 124
  • [12] Devon RS, 1997, PSYCHIATR GENET, V7, P165
  • [13] Dulawa S C, 1996, Chin J Physiol, V39, P139
  • [14] Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
    Geyer, MA
    Krebs-Thomson, K
    Braff, DL
    Swerdlow, NR
    [J]. PSYCHOPHARMACOLOGY, 2001, 156 (2-3) : 117 - 154
  • [15] Geyer MA, 1998, Current Protocols in Neuroscience
  • [16] GRAHAM FK, 1975, J EXP PSYCHOL HUMAN, V104, P161
  • [17] Intracerebral administration of metabotropic glutamate receptor agonists disrupts prepulse inhibition of acoustic startle in Sprague-Dawley rats
    Grauer, SM
    Marquis, KL
    [J]. PSYCHOPHARMACOLOGY, 1999, 141 (04) : 405 - 412
  • [18] STARTLE GATING DEFICITS OCCUR ACROSS PREPULSE INTENSITIES IN SCHIZOPHRENIC-PATIENTS
    GRILLON, C
    AMELI, R
    CHARNEY, DS
    KRYSTAL, J
    BRAFF, D
    [J]. BIOLOGICAL PSYCHIATRY, 1992, 32 (10) : 939 - 943
  • [19] Henry S. A., 1999, Society for Neuroscience Abstracts, V25, P449
  • [20] The mGluR5 antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity
    Henry, SA
    Lehmann-Masten, V
    Gasparini, F
    Geyer, MA
    Markou, A
    [J]. NEUROPHARMACOLOGY, 2002, 43 (08) : 1199 - 1209